Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:alternativeTo |
FSME-Immun
|
| gptkbp:approvedBy |
gptkb:Europe
1991 |
| gptkbp:ATCCode |
J07BA01
|
| gptkbp:broadcastOn |
primary series and booster doses
|
| gptkbp:contains |
inactivated tick-borne encephalitis virus
|
| gptkbp:containsAdjuvant |
aluminum hydroxide
|
| https://www.w3.org/2000/01/rdf-schema#label |
Encepur
|
| gptkbp:indication |
adults
children |
| gptkbp:manufacturer |
GlaxoSmithKline
|
| gptkbp:routeOfAdministration |
intramuscular injection
|
| gptkbp:sideEffect |
fever
fatigue headache injection site reactions |
| gptkbp:storage |
2-8°C
|
| gptkbp:usedFor |
prevention of tick-borne encephalitis
|
| gptkbp:WHOPrequalified |
no
|
| gptkbp:bfsParent |
gptkb:tick-borne_encephalitis
|
| gptkbp:bfsLayer |
7
|